Go to Samples
Olumiant 4 MG sample image

Eli Lilly and Co.

Olumiant 4 MG

30 x 4 mg oral tablet per bottle

Indications and Usage

Rheumatoid Arthritis

OLUMIANT® (baricitinib) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.

Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic disease-modifying antirheumatic drugs (DMARDs), or with potent immunosuppressants such as azathioprine and cyclosporine.

Coronavirus Disease 2019 (COVID-19)

OLUMIANT is indicated for the treatment of coronavirus disease 2019 (COVID-19) in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Alopecia Areata

OLUMIANT is indicated for the treatment of adult patients with severe alopecia areata.

Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.

More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows
Novant
Mayo
Duke
PANN
Ohio
UPMC
Novant
Mayo
Duke
PANN
Ohio
UPMC

HOW IT WORKS

The easy way to access samples

Confirm EligibilitySamples are available for authorized US healthcare providers
Create Free AccountRequest, track, and manage samples from multiple brands
Get your SampleSamples shipped directly to your practice door
Want to check your eligibility to order samples?

WHO IS PRESCRIBERPOINT

Increasing patient access to medications they need

At PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.
200K+Visitors Each Month
100K+Engagements Each Month
1M+Resources Viewed

WHAT HCPS ARE SAYING

FAQs

All you need to know to order samples

Currently, PrescriberPoint is available only in the U.S, but we are excited to expand our reach in the future! Stay connected by following us or signing up for our newsletter to get the latest updates, including announcements about new market launches.

Other Rheumatoid Arthritis Samples